Knowledge, Attitude and Practice Regarding Diagnosis and Management of Gout Among Clinicians in Nepal

Knowledge, Attitude and Practice Regarding Diagnosis and Management of Gout Among Clinicians in Nepal: A Report From Web-Based Survey

A web-based descriptive survey was conducted among doctors with regular interaction with gout patients. The questionnaire comprised of 38 multiple choice questions; 9 questions for demographic data, 8, 11 and 10 questions each for knowledge, attitude and practice, respectively. Simple descriptive statistics were used to describe the correct responses.

Study Overview

Status

Completed

Conditions

Detailed Description

Objective To understand the knowledge, attitude and treatment practices of gout among doctors who regularly interacted with gout patients.

Methodology Study population: Physicians (including practicing medical graduates, post-graduates in internal medicine, family medicine) and orthopedic surgeons were selected randomly from the list of data from the Nepal Medical Council registry. All internists with valid email ID on the registry of the "society of internal medicine of Nepal" (SIMON) were included. Also, a list of MBBS graduates, family medicine and orthopedic practitioners working in the peripheral set-up of Nepal was obtained and a random selection with computer-generated random number table based on council registration number was made for enrollment into the survey. Estimating a response rate of 30%, a total of 1200 clinicians were selected based on their council registration number for the invitation to participate in the survey.

Survey instrument: A standardized questionnaire was designed by a 3-member committee of NRA focusing on the areas of knowledge, attitude and practice of gout with 9 questions pertaining to demographic parameters, 8 to knowledge about the disease, 11 to attitude and 10 to practice behaviors [tables 1-4]. The questions were designed as multiple-choice questions (MCQ) to be marked by the respondent. Few questions had the provision of selecting more than 1 options. Open- ended questions were avoided to save the time of the respondents and thus reduce the attrition rates[10].

Procedure: An email containing a letter of invitation for participation was sent to each of the selected participant. It mentioned why they were receiving the email, the objectives of the survey, the assurance of anonymity and confidentiality and a total answering time of less than 5 minutes for encouraging participation. A link to the Google-form was attached in the mail itself and a mention was made on the implied consent for participation in clicking the link. A reminder email was sent after 1 week to all irrespective of whether they had responded earlier.

Platform: A web-based platform was chosen with the use of Google-forms which was compatible and user friendly to both browser and mobile users and to both iOS and Android users. Multiple entries from the same email link were blocked. Web-based platform was chosen over email survey because it provides the ability to transfer survey responses directly into a database, eliminating transcription errors and preventing survey alteration by the survey respondent and most importantly maintaining confidentiality and anonymity of respondents[11]. The answers were collected anonymously in an excel sheet at the main server for analysis.

Statistical analysis: Simple descriptive statistics were used to describe the frequency or correct responses. Chi-square test was performed to assess the difference in knowledge, attitude, and practices between clinicians with different medical qualifications. Analysis was done using SPSS version 21 (SPSS, Inc., Chicago, IL, USA).

Study Type

Observational

Enrollment (Actual)

380

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Kathmandu, Nepal
        • National center for Rheumatic Diseases

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Physicians (including practicing medical graduates, post-graduates in internal medicine, family medicine) and orthopedic surgeons were selected randomly from the list of data from the Nepal Medical Council registry. All internists with valid email ID on the registry of the "society of internal medicine of Nepal" (SIMON) were included.

Description

Inclusion Criteria:

  • Physicians (including practicing medical graduates, post-graduates in internal medicine, family medicine)
  • orthopedic surgeons
  • with valid email ID on the registry of the "society of internal medicine of Nepal" (SIMON)

Exclusion Criteria:

  • who did not give consent
  • clinicians other than above mentioned faculty

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
evaluation of knowledge
Time Frame: 3 months
evaluation of knowledge on gout among clinicians
3 months
evaluation of attitude
Time Frame: 3 months
evaluation of attitude on gout among clinicians
3 months
evaluation of practice
Time Frame: 3 months
evaluation of practice on gout among clinicians
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2019

Primary Completion (Actual)

December 31, 2019

Study Completion (Actual)

January 31, 2020

Study Registration Dates

First Submitted

August 16, 2020

First Submitted That Met QC Criteria

August 16, 2020

First Posted (Actual)

August 19, 2020

Study Record Updates

Last Update Posted (Actual)

August 19, 2020

Last Update Submitted That Met QC Criteria

August 16, 2020

Last Verified

August 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Gout

3
Subscribe